Pancreatic Cancer Subtypes Unveiled by BPGbio at ASCO GI 2025 for Tailored Treatment BPGbio, Inc., a clinical-stage biopharma company specializing in mitochondrial biology and protein homeostasis, today revealed new findings in pancreatic cancer subtyping from its long-term Project Survival® (NCT2781012)…
DNA Nanobots Appoints Dr. John C. Byrd to Scientific Advisory Board DNA Nanobots, a leader in biotechnology specializing in DNA nanoparticles for targeted therapeutics, has announced the addition of Dr. John C. Byrd, M.D., to its Scientific Advisory Board (SAB).…
Partners at Red Cell Welcome Timothy G. Ferris, MD, to Lead Healthcare Practice Red Cell Partners, a firm dedicated to incubating and investing in technology-driven companies that are revolutionizing healthcare, cyber, and national security, has announced that Dr. Timothy G.…
VSee Health Announces $935K Contracts with Leading Medical Device Manufacturers VSee Health, Inc. (Nasdaq: VSEE), a leading provider of comprehensive digital health services and tailored telehealth workflows, has secured contracts totaling approximately $935,000 with several prominent medical technology solution companies.…
Award-Winning PICO Nexμs to be Showcased by Nordson EFD at MD&M West 2025 Nordson EFD, a division of Nordson Corporation (NASDAQ: NDSN), will highlight its award-winning PICO Nexμs jetting system at MD&M West, scheduled to take place at the Anaheim…
Charles River Expands Apollo™ Ecosystem with Custom Client Experiences Charles River Laboratories International, Inc. (NYSE: CRL) today introduced Apollo™ for CRADL®, a secure cloud-based platform designed to enhance its vivarium rental services. This digital platform connects clients effortlessly with the…
Symposium 2025: Pulse Biosciences Presents Nanosecond PFA 360° Data Pulse Biosciences, Inc. (Nasdaq: PLSE), a company utilizing its innovative Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, announced today the late-breaking data from its first-in-human feasibility study of the Nanosecond PFA 360°…
Congress 2025: United Therapeutics to Present Clinical Data at PVRI Annual Event United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that it will present five posters showcasing data from its commercial and development portfolio in pulmonary hypertension…
Glox Therapeutics Wins £3M Cystic Fibrosis Funding Glox Therapeutics, a leader in developing precision antibiotic therapies using naturally occurring bacteriocins, has announced it has been awarded a portion of the £3 million Collaborative Discovery Programme (CDP) funding from the Cystic…
Know Labs, Inc. (NYSE American: KNW), a trailblazer in the development and application of radio frequency dielectric spectroscopy (RFDS), is excited to unveil the creation of its new business unit, Know Labs Technology Licensing (KTL). Drawing inspiration from the successful…
